464 related articles for article (PubMed ID: 16755211)
1. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
Cheng AY; Leiter LA
Curr Opin Cardiol; 2006 Jul; 21(4):400-4. PubMed ID: 16755211
[TBL] [Abstract][Full Text] [Related]
2. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
[TBL] [Abstract][Full Text] [Related]
3. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
[TBL] [Abstract][Full Text] [Related]
4. Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options.
Stone NJ; Bilek S; Rosenbaum S
Am J Cardiol; 2005 Aug; 96(4A):53E-59E. PubMed ID: 16098845
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: benefits versus risks.
McKenney JM
Am J Cardiol; 2005 Aug; 96(4A):60E-66E. PubMed ID: 16098846
[TBL] [Abstract][Full Text] [Related]
6. [New results in the management of hypercholesterolemia].
Sármán B
Orv Hetil; 2005 Sep; 146(39):1999-2004. PubMed ID: 16265867
[TBL] [Abstract][Full Text] [Related]
7. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.
Fazio S
Clin Ther; 2008 Feb; 30(2):294-306. PubMed ID: 18343268
[TBL] [Abstract][Full Text] [Related]
8. The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient.
Ong HT
QJM; 2005 Aug; 98(8):599-614. PubMed ID: 16006501
[TBL] [Abstract][Full Text] [Related]
9. Lipid-lowering therapy and the patient with multiple risk factors: what have we learned from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)?
Sever PS
Am J Med; 2005 Dec; 118 Suppl 12A():3-9. PubMed ID: 16356801
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of recent lipid trials on reducing risk in patients with type 2 diabetes mellitus.
Jones PH
Am J Cardiol; 2007 Feb; 99(4A):133B-140B. PubMed ID: 17307065
[TBL] [Abstract][Full Text] [Related]
11. Statins and diabetes.
Carmena R; Betteridge DJ
Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
[TBL] [Abstract][Full Text] [Related]
12. Rising to the challenge of treating high-risk patients.
Guthrie RM
Am J Manag Care; 2006 Oct; 12(11 Suppl):S318-24. PubMed ID: 17042674
[TBL] [Abstract][Full Text] [Related]
13. Protecting the heart: a practical review of the statin studies.
Ong HT
MedGenMed; 2002 Dec; 4(4):1. PubMed ID: 12817199
[TBL] [Abstract][Full Text] [Related]
14. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
[TBL] [Abstract][Full Text] [Related]
15. Critical appraisal of revised cholesterol guidelines for the very high-risk patient.
Rosenson R; Lloyd-Jones D;
Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):173-8. PubMed ID: 15739256
[TBL] [Abstract][Full Text] [Related]
16. The safety and efficacy of achieving very low LDL-cholesterol concentrations with high dose statin therapy.
Wiviott SD; Cannon CP
Curr Opin Lipidol; 2006 Dec; 17(6):626-30. PubMed ID: 17095906
[TBL] [Abstract][Full Text] [Related]
17. Update on lipid-lowering therapy and LDL-cholesterol targets.
Wiviott SD; Cannon CP
Nat Clin Pract Cardiovasc Med; 2006 Aug; 3(8):424-36. PubMed ID: 16874355
[TBL] [Abstract][Full Text] [Related]
18. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
Sorensen SV; Frick KD; Wade A; Simko R; Burge R
Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
[TBL] [Abstract][Full Text] [Related]
19. Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering.
Jones PH
Am J Cardiol; 2008 Dec; 102(12A):41L-47L. PubMed ID: 19084089
[TBL] [Abstract][Full Text] [Related]
20. Beyond LDL cholesterol: the role of elevated triglycerides and low HDL cholesterol in residual CVD risk remaining after statin therapy.
Alagona P
Am J Manag Care; 2009 Mar; 15(3 Suppl):S65-73. PubMed ID: 19355805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
